Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy

Adv Sci (Weinh). 2021 May 16;8(14):2100540. doi: 10.1002/advs.202100540. eCollection 2021 Jul.

Abstract

Gene therapy provides a promising strategy for curing monogenetic disorders and complex diseases. However, there are challenges associated with the use of viral delivery vectors. The advent of nanomedicine represents a quantum leap in the application of gene therapy. Recent advances in stimulus-responsive nonviral nanocarriers indicate that they are efficient delivery systems for loading and unloading of therapeutic nucleic acids. Some nanocarriers are responsive to cues derived from the internal environment, such as changes in pH, redox potential, enzyme activity, reactive oxygen species, adenosine triphosphate, and hypoxia. Others are responsive to external stimulations, including temperature gradients, light irradiation, ultrasonic energy, and magnetic field. Multiple stimuli-responsive strategies have also been investigated recently for experimental gene therapy.

Keywords: gene therapy; nonviral vector; stimulus‐responsive nanocarriers; viral vector.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Carriers / therapeutic use*
  • Genetic Therapy / methods*
  • Humans
  • Nanoparticles / administration & dosage*

Substances

  • Drug Carriers